Back story here.
Two former Bristol-Myers Squibb Co. executives entered not-guilty pleas to a new indictment charging them with misleading investors about drug inventory practices that inflated sales by $1.95 billion.
Frederick Schiff, a former finance chief, and Richard J. Lane, who oversaw worldwide medicines, were indicted for a third time April 12.
They are accused of arranging tens of millions of dollars in incentives to spur wholesalers to buy more drugs than they needed.
New York-based Bristol-Myers Squibb paid $300million to avoid prosecution for the practice.
No comments:
Post a Comment